scispace - formally typeset
J

Josef Smolle

Researcher at Medical University of Graz

Publications -  340
Citations -  8772

Josef Smolle is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Melanoma & Melanocytic nevus. The author has an hindex of 49, co-authored 337 publications receiving 8424 citations. Previous affiliations of Josef Smolle include Max Planck Society & University of Graz.

Papers
More filters
Journal ArticleDOI

Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients.

TL;DR: The study confirmed that the EORTC classification allows a better management of patients with PCL and small amendments to that classification should be carried out to account for recently described entities and to unify some of the diagnostic categories.
Journal ArticleDOI

Diagnostic Applicability of In Vivo Confocal Laser Scanning Microscopy in Melanocytic Skin Tumors

TL;DR: This first sensitivity and specificity study with CLSM has yielded promising results, and CLSM provides new and useful information to the clinician diagnosing melanocytic skin tumors.
Journal ArticleDOI

Epidemiology of tinea capitis in Europe: current state and changing patterns.

TL;DR: The results of the study clearly demonstrate the importance of diagnosing and proper treatment of mycotic scalp infection in the Europe and the increased level of surveillance, and a highly effective interdisciplinary cooperation among general practitioners, mycologists, veterinarians and dermatologists are strongly recommended.
Journal ArticleDOI

Phase II Trial of a Toll-Like Receptor 9–Activating Oligonucleotide in Patients With Metastatic Melanoma

TL;DR: It is indicated that TLR 9-targeted therapy can stimulate innate immune responses in cancer patients, identify biomarkers that may be associated with TLR9-induced tumor regression, and encourage the design of follow-up studies to evaluate the ability of this therapeutic approach to target human cancer.
Journal ArticleDOI

Specific Cutaneous Infiltrates of B-cell Chronic Lymphocytic Leukemia: A Clinicopathologic and Prognostic Study of 42 Patients

TL;DR: It is indicated that cutaneous specific manifestations of B-CLL present with characteristic histologic, immunophenotypic, and molecular patterns and is likely that prognosis in these patients is probably not affected by skin involvement.